USANA HEALTH SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-01-02 was 89.00K shares, a 90.71% decline year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-10-03 was 103.00K shares, a 142955.56% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-07-04 was 195.00K shares, a 96434.65% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2015-04-04 was 55.00K shares, a 34275.00% increase year-over-year.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2019 was 189.00K shares, a 78.52% decline from fiscal 2018.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2018 was 880.00K shares, a 0.45% decline from fiscal 2017.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2017 was 884.00K shares, a 8.96% decline from fiscal 2016.
- USANA HEALTH SCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 971.00K shares, a 119.68% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2019-12-28 | 189.00K shares 10-K · filed 2020-02-25 | |
| 2018-12-29 | 880.00K shares 10-K · filed 2019-02-26 | |
| 2017-12-30 | 884.00K shares 10-K · filed 2018-02-28 | |
| 2016-12-31 | 971.00K shares 10-K · filed 2017-03-01 | |
| 2016-01-02 | 89.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | 442.00K shares 10-K · filed 2016-03-01 |
| 2015-10-03 | 103.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 1.31M shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-07-04 | 195.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | 1.21M shares derived: sum of 4 quarters · filed 2015-08-12 |
| 2015-04-04 | 55.00K shares 10-Q · filed 2015-05-13 | 1.01M shares derived: sum of 4 quarters · filed 2015-05-13 |
| 2015-01-03 | 957.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | 958.00K shares 10-K · filed 2015-03-17 |
| 2014-09-27 | 72.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | |
| 2014-06-28 | 202.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | |
| 2014-03-29 | 160.00 shares 10-Q · filed 2014-05-07 | |
| 2013-12-28 | 939.00K shares 10-K · filed 2014-03-13 | |
| 2012-12-29 | 1.40M shares 10-K · filed 2013-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |